Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
Public ClinicalTrials.gov record NCT01302119. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of AN2690 Topical Solution, 5%, vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenail in Adults
Study identification
- NCT ID
- NCT01302119
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 604 participants
Conditions and interventions
Conditions
Interventions
- AN2690 Topical Solution, 5% Drug
- Solution Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2011
- Primary completion
- Dec 30, 2012
- Completion
- Feb 19, 2013
- Last update posted
- Apr 2, 2019
2011 – 2013
United States locations
- U.S. sites
- 26
- U.S. states
- 18
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Phoenix | Arizona | 85050 | — |
| Investigational Site | Novato | California | 94945 | — |
| Investigational Site | Oceanside | California | 92056 | — |
| Investigational Site | San Diego | California | 92123 | — |
| Investigational Site | San Francisco | California | 94115 | — |
| Investigational Site | Santa Rosa | California | 95405 | — |
| Investigational Site | Miami | Florida | 33144 | — |
| Investigational Site | Miami | Florida | 33175 | — |
| Investigational Site | Nampa | Idaho | 83642 | — |
| Investigational Site | Evansville | Indiana | 47714 | — |
| Investigational Site | Ann Arbor | Michigan | 48103 | — |
| Investigational Site | St Louis | Missouri | 63117 | — |
| Investigational Site | Verona | New Jersey | 07044 | — |
| Investigational Site | Albuquerque | New Mexico | 87106 | — |
| Investigational Site | High Point | North Carolina | 27262 | — |
| Investigational Site | Raleigh | North Carolina | 27612 | — |
| Investigational Site | Columbus | Ohio | 43212 | — |
| Investigational Site | Portland | Oregon | 97223 | — |
| Investigational Site | Philadelphia | Pennsylvania | 19103 | — |
| Investigational Site | Greer | South Carolina | 29651 | — |
| Investigational Site | Knoxville | Tennessee | 37922 | — |
| Investigational Site | Dallas | Texas | 75243 | — |
| Investigational Site | San Antonio | Texas | 78209 | — |
| Investigational Site | Salt Lake City | Utah | 84124 | — |
| Investigational Site | Harrisonburg | Virginia | 22801 | — |
| Investigational Site | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01302119, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2019 · Synced Apr 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01302119 live on ClinicalTrials.gov.